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ERα suppresses slug expression directly by transcriptional repression
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Two of the most common signalling pathways in breast cancer
are the ER (oestrogen receptor) ligand activation pathway
and the E-cadherin–snai1–slug–EMT (epithelial–mesenchymal
transition) pathway. Although these pathways have been thought
to interact indirectly, the present study is the ﬁrst to observe direct
interactions between these pathways that involves the regulation
of slug expression. Speciﬁcally we report that ligand-activated
ERα suppressed slug expression directly by repression of
transcription and that knockdown of ERα with RNA interference
increased slug expression. More speciﬁcally, slug expression was
down-regulated in ERα-negative MDA-MB-468 cells transfected
with ERα after treatment with E2 (17β-oestradiol). The down-
regulation of slug in the ERα-positive MCF-7 cell line was
mediated by direct repression of slug transcription by the
formation of a co-repressor complex involving ligand-activated
ERα protein,HDAC1(histonedeacetylase1)andN-CoR(nuclear
receptor co-repressor). This ﬁnding was conﬁrmed by sequential
ChIP(chromatinimmunoprecipitation)studies.IntheMCF-7cell
line, slug expression normally was low. In addition, knockdown
of ERα with RNA interference in this cell line increased slug
expression. This effect could be partially reversed by treatment
of the cells with E2. The efﬁcacy of the effect of ERα on slug
repression was dependent on the overall level of ERα.T h e s e
observations conﬁrmed that slug was an E2-responsive gene.
Key words: oestrogen receptor α (ERα), oestrogen receptor
α co-regulator complex, real-time PCR, RNA interference,
sequential ChIP analysis, slug.
INTRODUCTION
Two of the most common signalling pathways in breast cancer
are the ER (oestrogen receptor) ligand activation pathway and
the E-cadherin–snai1–slug [where snai1 is snail homologue 1
and slug (also known as snai2) is snail homologue 2]–EMT
(epithelial–mesenchymal transition) pathway. ERα is a ligand-
activatednuclearhormonereceptorthatregulatesthetranscription
of oestrogen-responsive genes in diverse target cells [1]. ERα
and its main ligand, E2 (17β-oestradiol), play a critical role in
many of the biological processes of normal cells located in the
breast, reproductive tract, central nervous system, skeleton and
immune system [1]. Similarly ERα and its ligand regulate key
pathways in ERα-positive human breast cancer. Two functional
domains have been identiﬁed in ERα, the transcription activation
function domain 1 (termed AF-1) in the N-terminus and domain
2 (termed AF-2) which binds ligand. The AF-1 domain is ligand-
independent and constitutive, whereas the function of AF-2 is
completely dependent on ligand binding [2–5]. According to the
classical model of ER action, in the absence of hormone, the
receptor is sequestered in a multiprotein inactive complex in
either the cytoplasm or nuclei of target cells. The binding of
ligand induces an activating conformational change within the
ER, promoting dimerization and high-afﬁnity binding to speciﬁc
EREs(oestrogen-responseelements)locatedwithintheregulatory
regions of target genes [6]. These ‘co-activator’ complexes
enable the ER: (i) to respond appropriately to hormones or
pharmacological ligands, (ii) to interpret extra- and intra-cellular
signals, (iii) to catalyse the process of chromatin condensation,
and (iv) to communicate with the general transcription apparatus
at target gene promoters [6]. The action of ligand-activated ERα
is not limited to genes with EREs. Ligand-activated ERα can
interact in anindirect manner with the regulatory regions of target
genes lacking EREs. For example, ERα-mediated expression of
the collagenase and IGF-1 (insulin-like growth factor 1) genes
is mediated through the interaction of ERα with Fos and Jun at
AP-1 (activator protein 1)-binding sites [6]. In any case, ligand
activation of ERα sets off a complex series of gene activations in
the human breast cancer cell. The ER ligand activation pathway
is one of the most important signalling pathways in human breast
cancer that has been targeted therapeutically.
TheE-cadherin–snai1–slugEMTpathwayisanotherimportant
pathway in human breast cancer progression thought to regulate
tumour progression, invasion and metastasis of certain types of
human breast cancer [7,8]. The snail transcription family consist-
ing of members snai1 and snai2 (slug) is thought to repress E-
cadherin expression, leading to EMT [7]. Snail-induced EMT
converts epithelial cells into mesenchymal cells with migratory
properties that contribute to the formation of many tissues
during embryonic development and to the acquisition of invasive
properties in epithelial tumours. Snail-induced EMT is partly due
to the direct repression of E-cadherin transcription both during
development and tumour progression [9]. This pathway is also
activated in malignant mesothelioma and other carcinomas [7,8].
Althoughsnail (snai1andsnai2)hasbeenmostly studiedinEMT,
evenwhentumoursdonotexhibitclassicEMT,up-regulatedsnai1
orsnai2(slug)maymediateinvasionandmetastasis.Insquamous
cell carcinomas of the oesophagus, tumours with positive slug
expression, for example, invaded deeper, had more lymph node
metastasis, and had more lymphatic invasion than tumours with
Abbreviations used: AF-1 (2), activation function domain 1 (2); ChIP, chromatin immunoprecipitation; DCC-FBS, dextran-coated charcoal-treated FBS;
DMEM, Dulbecco’s modiﬁed Eagle’s medium; E2, 17β-oestradiol; EMT, epithelial–mesenchymal transition; ER, oestrogen receptor; ERE, oestrogen-
response element; FBS, foetal bovine serum; HDAC, histone deacetylase; HDACI, HDAC inhibitor; IKKα, inhibitor of NF-κB (nuclear factor κB) kinase α;
miRNA, microRNA; N-CoR, nuclear receptor co-repressor; ORF, open reading frame; RNAi, RNA interference; SeqChIP, sequential ChIP; siRNA, small
interfering RNA; slug (snai2), snail homologue 2; snai1, snail homologue 1; SRC-3, nuclear receptor co-activator; TBST, TBS containing 0.1% Tween 20.
1 To whom correspondence should be addressed (email sanford.barsky@osumc.edu).
c   The Authors Journal compilation c   2008 Biochemical Society © 2008 The Author(s)
The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/)
which permits unrestricted non-commerical use, distribution and reproduction in any medium, provided the original work is properly cited.
www.biochemj.org
B
i
o
c
h
e
m
i
c
a
l
 
J
o
u
r
n
a
l180 Y. Ye and others
negative slug expression [10]. Although the functions of slug
during EMT, invasion and metastasis are being elucidated, com-
paratively little is known about slug regulation.
Asthemajorsignallingpathwaysinbreastcancercontinuetobe
characterized,itisimportanttoidentifyinteractionsbetweenthese
pathwayssothattheycanbeunderstoodmorefully.Becauseofthe
inverse correlation that we had observed recently (Y. Ye, Y. Xiao,
W. Wang, K. Yearsley, J.-X. Gao and S. H. Barsky, unpublished
work) between ER and slug expression in a number of different
ER-positive and ER-negative human breast carcinoma cell lines,
we wondered whether the two pathways, previously thought to
interact indirectly [11], might, in fact, interact directly.
MATERIALS AND METHODS
Reagents and antibodies
Antibodies against ERα (D-12), HDAC (histone deacetylase)
3 (H-99), N-CoR (nuclear receptor co-repressor; H-303) and
HDAC4 (H-92) were purchased from Santa Cruz Biotechnology.
Antibodies against HDAC1, SRC-3 (nuclear receptor co-
activator; 11B1), IKKα [inhibitor of NF-κB (nuclear factor κB)
kinase α]a n dβ-actin (13E5) were purchased from Cell Signaling
Technology.SecondaryantibodiesandWesternblottingsubstrates
were purchased from Pierce Technology, and used according
to the manufacturer’s instructions. E2 and a speciﬁc HDACI
(HDACinhibitor)werepurchasedfromEMDChemicals.Plasmid
constructs and related reagents were purchased from Invitrogen.
Cell culture
We used a series of commercially available cell lines, including
theERα-positivehumanbreastcarcinomacelllineMCF-7andthe
ERα-negative human breast carcinoma cell line MDA-MB-468.
AllofthesecelllinesweregrowninDMEM(Dulbecco’smodiﬁed
Eagle’s medium) with 10% (v/v) FBS (foetal bovine serum) or
with 5% (v/v) DCC-FBS (dextran-coated charcoal-treated FBS).
Plasmid construction and transfections
Human full-length ERα Ultimate ORF (IOH34665; ORF is open
readingframe)waspurchasedfromInvitrogen.TheERαORFwas
clonedintotheentryvectorpENTR221andsubclonedintovectors
pcDNA6.2/V5 using the LR recombination reaction according
to the manufacturer’s instructions (Invitrogen). We initially per-
formed transient transfections and subsequently performed stable
transfections with clonal selection. The recombinant vector
pcDNA6.2/V5-ERα containing ERα ORF or the empty (control)
vector pcDNA6.2/V5 was transfected directly into cultured cells
using Lipofectamine
TM 2000 (Invitrogen) for either transient or
stabletransfection.Blasticidin (10 μg/ml)(EMDChemicals)was
used to select for stable clones.
Knockdown of ERα was achieved with an RNAi (RNA inter-
ference) approach using either miRNA (microRNA) to obtain
stable clones, or siRNA (small interfering RNA) for transient, but
more effective, knockdown. The nucleotide sequences of ERα
miRNAwereasfollows:5
 -TGCTGAGTCATTGCACACTGCA-
CAGTGTTTTGGCCACTGACTGACACTGTGCAGTGCAAT-
GACT-3
  (sense) and 5
 -CCTGAGTCATTGCACTGCACA-
GTGTCAGTCAGTGGCCAAAACACTGTGCAGTGTGCAA-
TGACTC-3
  (antisense). These single strands of miRNA were
annealedtoformdouble-strandmiRNADNAandinsertedintothe
BLOCK-iT Pol II miR RNAi Expression vector, pcDNA6.2-GW/
EmGFP-miR(Invitrogen).MCF-7cellsweregrownovernightand
transfected with recombinant plasmid pcDNA6.2-GW/EmGFP-
miR-ERα that expressed ERα miRNA or empty plasmid (negat-
ive control). Blasticidin (10 μg/ml) was used to select for stable
clones.
For the siRNA-knockdown experiments, ERα siRNA se-
quences included: 5
 -CGAGUAUGAUCCUACCAGAII-3
 
(sense) and 5
 -UCUGGUAGGAUCAUACUCGGA-3
  (anti-
sense). MCF7 cells were maintained in Phenol-Red-free DMEM
supplemented with 5% (v/v) DCC-FBS for 48 h. Cells were
then transfected with 50 nM of either control siRNA or ERα
siRNA. After 48 h, the cells were serum-starved for 12 h and
either untreated or treated with E2 for 4 h.
RNA isolation and cDNA synthesis
Total RNA was isolated from cultured cells using an RNeasy
Mini Kit (Qiagen) according to the manufacturer’s instructions.
Total RNA was eluted and dissolved in RNase-free water,
and the concentration was determined using a NanoDrop®
spectrophotometer (NanoDrop Technologies). For the ﬁrst-strand
cDNA synthesis, the SuperScript® III First-Strand Synthesis
System (Invitrogen), oligo(dT)20 and 2 μg of total RNA were
used.ThesynthesizedcDNAwasusedforreal-timePCRanalysis
of relative expression levels of target genes.
PCR and real-time PCR
Brieﬂy, an aliquot of DNA was used in each 25 μl PCR reaction.
The following conditions were used: an initial denaturation at
95◦C for 5 min followed by denaturation at 94◦C for 30 s,
annealing at 58◦C for 30 s, and extension at 68◦Cf o r1m i nf o ra
totalof30cycles.PCRproductswereanalysedona2.0%agarose
gel.Real-timePCRwasperformedonaABI7500® real-timePCR
system (Applied Biosystems). cDNA was combined with primer
sets and the ABI Power SYBR Green PCR Master Mix. The PCR
conditions were as follows: 95◦C for 15 s and 60◦Cf o r1m i n
for 40 cycles. Gene expression levels were calculated relative to
the housekeeping gene β-actin by using ABI 7500® System SDS
software. The primers used for analysis of slug mRNA were: 5
 -
CTGGTCAA GAAGCATTTCAACGCC-3
  (sense) and 5
 -AAA-
GAGGAGAGAGGCCATTGGGTA-3
  (antisense). The primers
used for analysis of ERα mRNA were: 5
 -CGCTACTGTGCAG-
TGTGCAAT-3
  (sense) and 5
 -CCTCACAGGACCAGACTCC-
ATAA-3
  (antisense). The primers used for the analysis of
β-actin were: 5
 -GGCACCCAGCACAATGAAG-3
  (sense), 5
 -
GCCGATCCACACGGAGTACT-3
  (antisense).
Preparation of protein lysates and Western blot analysis
Cells were lysed using ice-cold RIPA lysis buffer [50 mM Tris/
HCl,150 mMNaCl,50 mMNaF,1 mMNa4P2O7 ·10H2O,0.1%
DOC(deoxycorticosterone),1.0%NonidetP40,50 μlofNa 3VO4
and Halt Protease Inhibitor Cocktail (Pierce Technology)].
After 15 min on ice with shaking, the lysates were centrifuged
at 15000 g for 10 min at 4◦C. Supernatants were stored at
−80◦C. For Western blot analysis, protein concentrations were
determined using the BCA (bicinchoninic acid) protein assay
(Pierce Technology). Equal amounts of denatured protein were
loadedontoa15%PrecastGel(Bio-Rad)andtransferredtonitro-
cellulose membranes (Bio-Rad). The membranes were washed
in TBST buffer [TBS (Tris-buffered saline, 20 mM Tris and
150 mM NaCl with the pH adjusted to 7.6 with HCl] containing
0.1% Tween 20] and non-speciﬁc binding sites were blocked
by immersing the membranes in blocking reagent (0.5% non-fat
dried skimmed milk in TBST buffer) for 1 h at room temperature
(23◦C) on a shaker. After washing with TBST buffer, membranes
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were incubated overnight at 4◦C with relevant antibodies to
ERα and β-actin separately in blocking buffer. Membranes were
then washed and incubated with secondary antibody for 1 h at
room temperature. After incubation, the membranes were further
washedinTBST.Boundantibodiesweredetectedwiththechemi-
luminescent detection system (Pierce Technology).
ChIP (chromatin immunoprecipitation), SeqChIP (sequential ChIP)
and Re-ChIP analyses
The ChIP assay was performed using a ChIP kit (Millipore)
accordingtothemanufacturer’sinstructions.Brieﬂy,2×10
6 cells
were treated with 1% formaldehyde for 10 min at 37◦C. The
cells were harvested, suspended with SDS lysis buffer [1% SDS,
10 mM EDTA and 50 mM Tris/HCl (pH 8.3)], and incubated on
ice for 10 min. Lysates were sonicated, and debris was removed
from the samples by centrifugation for 10 min at 10000 g.A n
aliquot of each chromatin solution (40 μl) was set aside and
designatedastheinputfraction.Supernatantswerediluted10-fold
in immunoprecipitation buffer and precleared with Protein A–
agarose beads that had been pre-absorbed with salmon sperm
DNA. The precleared chromatin solution was incubated with the
relevant antibodies to ERα, HDACs 1, 3 and 4, N-CoR, IKKα
and SRC-3 separately for 16 h at 4◦C. Normal IgG was used as a
negativecontrol.Theimmunecomplexeswerethencollectedwith
the addition of Sepharose A/G plus agarose beads, followed by
several washes with appropriate buffers, according to the manu-
facturer’s instructions. Each sample was eluted with freshly
prepared 1% SDS and 0.1 M NaHCO3, and then histone–
DNA cross-links were reversed with the addition of 5 M NaCl.
Chromatin-associated proteins were digested with proteinase K
(10 mg/ml), and the immunoprecipitated DNA was recovered
by phenol/chloroform extraction and ethanol precipitation and
analysed by PCR. The primers used for ChIP were as follows:
slug (−456 to −68) 5
 -TGGTCTTTGTGCAAGGCAAACC-
TC-3
  (sense) and 5
 -AGGTTCAGATTTCAGCTCCTCCCT-3
 
(antisense); slug (−2178 to −1973) 5
 -ACCTGTTTCGTCTG-
ACTCAC GCCATC-3
  (sense), 5
 -CCATCAGCAGGTATCC-
GAGGGTGC-3
  (antisense).
ForsequentialChIPandRe-ChIP,chromatinfrom5×10
8 cells
was incubated with ERα antibody for 16 h at 4◦C. Normal
IgG was used as a negative control. The immune complexes were
then collected with the addition of Sepharose A/G plus agarose
beads, followed by several washes with appropriate buffers,
according to the manufacturer’s protocol. The supernatant of
eachsamplewaskeptforfurtherSeqChIP.Precipitatedcomplexes
from each sample were eluted by 10 min incubation with 300 μl
of elution buffer [50 mM Tris/HCl (pH 7.5), 10 mM EDTA and
1% SDS] at 68◦C. A 10 μl aliquot was removed from each
elution sample for analysis of the ﬁrst immunoprecipitation and
as input DNA. The remaining elution fraction was used for Re-
ChIP. Aliquots of the elution fraction (90 μl) were incubated with
the antibodies (ERα, HDAC3, HDAC1 or N-CoR) and the ChIP
assay was performed as described above. For SeqChIP, 40 μl
of supernatant was removed from each sample and set as input
fractions. An aliquot of each supernatant sample was incubated
with antibodies (ERα, HDAC3, HDAC1 or N-CoR) and the ChIP
assay was performed as described previously.
Statistical analysis
Differences in slug gene expression between selected clones were
analysed with the two-tailed Student’s t test as well as ANOVA.
RESULTS
The stimulation of E2 results in suppression of slug expression in
ERα-transfected MDA-MB-468 cells
To investigate the effect of ERα on the expression of slug, we
initially performed transient transfections of full-length ERα
into ERα-negative MDA-MB-468 cells. The recombinant vector
pcDNA6.2/V5-ERα containing ERα or the empty (control) vec-
tor pcDNA6.2/V5 was transfected directly into cultured MDA-
MB-468cells.At3 daysaftertransfection,thecellswereanalysed
forERα proteinlevelsbyWesternblotandslugmRNAusingreal-
time PCR. The results showed that ERα was overexpressed in
pcDNA6.2/V5-ERα-transfected cells, but not in the empty (con-
trol) vector-transfected cells (Figure 1A). Although we observed
a small increase in slug mRNA levels in cells transfected with
pcDNA6.2/V5-ERα alone in the absence of E2, we observed a
more dramatic decrease in slug mRNA when these cells were
treated with E2 (Figure 1B). Cells transfected with the empty
(control) vector showed no increase or decrease in slug mRNA in
either the absence or presence of E2 respectively (Figure 1B). For
the stable transfections, we used blasticidin to initially select for
35 different clones of MDA-MB-468. Of these, 21 clones over-
expressed ERα by both real-time PCR and Western blot analysis
(Figure 1C). In some of the stably transfected ERα-expressing
MDA-MB-468 clones, the expression of the slug gene was
augmented in the absence of E2. In other clones the unliganded
ERα had no effect on slug gene expression, but E2 dramatically
suppressed slug expression. Based on these observations, it could
be concluded that ERα was a bi-functional regulator for the
expression of the slug gene, in that the unliganded ERα was
an activator, whereas the E2-bound-ERα acted as a repressor,
depending upon the speciﬁc clone studied. We wondered whether
our observations might be more than just stochastic and related
to the levels of ERα expressed by each clone. We measured the
levels of ERα protein by Western blot analysis in the different
clones and investigated whether the effects of unliganded ERα
were activating and whether the effects of E2-bound-ERα were
repressing based on the levels of ERα. What we observed was
very interesting. In clones 4 and 23 ERα was expressed at very
high levels (Figure 1D), and it was in these two clones that E2-
bound-ERα repression of slug was far greater and statistically
signiﬁcant (P<0.01) than the activating effects of unliganded
ER which were not statistically signiﬁcant (P>0.1) (Figure 1C).
In clones 2 and 17 where ERα expression was much lower
(Figure 1D), the activating effects of unliganded ER were greater
than the repression effects of E2-bound ERα, but both were
statistically signiﬁcant (P<0.01 and P<0.05) (Figure 1C). A
similar pattern of activation versus repression was exhibited by
the remaining clones depending on their relative levels of ERα.
Ourresultsinthesestable-transfectionexperimentswithrespectto
slug repression conﬁrmed the results of our transient-transfection
experiments. Collectively the transfection experiments indicated
that E2 resulted in down-regulation of slug in transfected MDA-
MB-468cellsoverexpressingERα,withthemostdramaticeffects
observed in those clones with the highest levels of ERα.I no t h e r
words,slugisanE2-responsivegenewhenERα isoverexpressed,
and the amount of E2-induced slug repression directly relates to
the levels of ERα.
Knockdown of ERα results in the increase of slug mRNA levels in
MCF-7 cells
As a ligand-activated nuclear hormone receptor, ERα and its
ligandE2regulatethetranscriptionofmanyoestrogen-responsive
genes in diverse target cells. In addition to examining the effects
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Figure 1 The expression of slug in response to stimulation by E2 in transfected MDA-MB-468 cells overexpressing ERα
The recombinant vector pcDNA6.2/V5-ERα (pcDNA-ERα) containing ERα ORF or empty vector pcDNA6.2/V5 (pcDNA) was transfected into MDA-MB-468 cells using LipofectamineTM 2000.
(A) Transiently transfected cells were harvested and analysed for ERα protein by Western blotting. (B) Transiently transfected cells were maintained in Phenol-Red-free DMEM with 5% DCC-FBS for
48h, and after 12h of serum starvation, cells were treated with either ethanol vehicle (control) or E2 (100nM) for 4 h. The cells were then harvested and analysed for slug mRNA by real-time PCR.
Values are means+ −S.D. (C) Stably transfected clones overexpressing ERα were similarly maintained, treated and analysed. Four such clones are depicted. Values are means+ −S.D. (D) Western
blot showing ERα protein levels in each stably transfected clone expressing ERα. Clones 4 and 23 showed the highest ERα protein levels. These same clones showed the greatest E2 repression
of slug.
of ERα overexpression as noted previously, we decided to knock-
down ERα in a naturally ERα-expressing line, e.g. MCF-7, in
order to monitor the effects on endogenous slug expression, a
situation perhaps more physiologically relevant than the situation
ofoverexpression.ToinvestigatetheeffectofERα knockdownon
the expression of slug, ERα miRNA was transfected into parental
MCF-7 cells and stable clones were selected with blasticidin. A
total of 38 clones were selected and analysed for ERα mRNA
levels by real-time PCR. We observed that ERα expression
was signiﬁcantly reduced to different levels in various clones
(Figure 2A). These clones also showed signiﬁcant increases in
slug mRNA expression (Figure 2A). We then treated selected
clones with E2 (clones 19 and 20). The ERα level of clone 19
by real-time PCR was higher than in clone 20, but when treated
with E2 slug expression was decreased more in clone 19 than
in clone 20 (Figure 2B). This suggested the possibility that E2
caused a stronger response in clone 19 because clone 19 had
greater residual ERα. Another possibility was the existence of an
E2–ERα-independent mechanism. To resolve these possibilities
we needed to examine the levels of ERα protein expression in
the different clones and we needed to carry out more effective
ERα knockdown. The levels of ERα in the different clones by
Western blot analysis (Figure 2C) generally correlated with the
mRNAlevelsbyreal-timePCR(Figure2A).Todeterminefurther
whether the effects on repression of slug expression by E2 were
mediated by residual levels of ERα, which was our hypothesis,
or ERα-independent mechanisms, which was another possibility,
we carried out siRNA transient ERα knockdown and were able
to achieve a more signiﬁcant and near total knockdown of ERα
(Figure 2D). With the subsequent addition of E2, we did not
observe any repression of slug expression (Figure 2E). Therefore
we concluded that the effects on slug repression were indeed
mediated by ERα. Therefore slug was also an E2-responsive gene
when ERα was knocked down, and the amount of E2-induced
slug repression was again related to the residual levels of ERα
remaining.
Ligand-activated ERα associates with the slug promoter
Based on the aforementioned ﬁndings, we hypothesized that
ligand-activated ERα directly binds to the promoter regulatory
regions of slug and recruits known ERα co-regulators to form
transcriptional complexes that regulate slug transcription. A
search for speciﬁc EREs located within the slug promoter using
MatInspector® Software (Genomatix® Software) did not reveal
any classical ERE sites. However, the search revealed three half-
siteEREsfoundatpositions−467,+182and+241respectively.
To investigate whether ERα forms a transcriptional complex at
these sites within the slug promoter, we performed ChIP assays.
In these studies, we used the ERα-positive MCF-7 cell line as
the positive control and the untransfected ERα-negative MDA-
MB-468 cell line as the negative control. Based on the location
of the putative half-site EREs, we chose a region of the slug
promoter ﬂanked by these sites and a region located far upstream
of these sites as a negative control and also for normalization of
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Figure 2 Knockdown of ERα leading to the up-regulation of slug
(A) MCF-7 cells were transfected with plasmid pcDNA6.2-GW/EmGFP-miR-ERα that contained ERα miRNA or negative-control plasmid pcDNA6.2-GW/EmGFP-Neg ERα. The blasticidin-resistant
stably transfected clones were screened and analysed for the ERα mRNA level by real-time PCR. The transcription of slug was up-regulated when ERα was knocked down. Values are means+ −S.D.
(B)Stablytransfectedclones19and20weremaintainedinPhenol-Red-freeDMEMwith5%DCC-FBSfor48h,andafter12hofserumstarvation,thecloneswereeitheruntreatedortreatedwithE2
(100nM) for 4h. Total RNA was extracted and used for the analysis of the expression of slug by real-time PCR. Values are means+ −S.D. (C) Western blot showing ERα protein levels in each clone
expressing miR RNAi. Clone 19 had the highest residual ERα levels by both real-time PCR as well as Western blot analysis and a signiﬁcant repression of slug by E2. (D) Western blot showing ERα
protein levels in cells treated with or without ERα siRNA and with or without E2. The siRNA approach was very effective at ERα knockdown. (E) Real-time PCR showing slug mRNA levels in cells
treated with or without ERα siRNA and with or without E2. Total RNA was extracted and analysed for slug mRNA by real-time PCR. With effective ERα knockdown, E2 was not able to repress slug.
Values are means+ −S.D.
ChIP signals between the two cell lines. In the MCF-7 cells, E2
treatment led to the recruitment of ERα to the −456 to −68, but
notthe−2178to−1973,regionoftheslugpromoter(Figure3A).
In MDA-MB-468 cells, there was no association of ERα to the
−456 to −68 region of the slug promoter (Figure 3B). These
results indicate that ligand-activated ERα is recruited to the slug
promoter in the region spanning the half-site EREs (Figure 3C).
HDAC1 co-represses the expression of slug
A number of different co-repressors interacting with ligand-
activated ERα had been identiﬁed in recent years. Among them,
HDACs were known to regulate chromatin structure through
histone modiﬁcation and direct interaction with transcription
factors [12]. It has been reported that HDAC1 interacted with the
AF-2 domain of ERα and suppressed ERα transcription activity
[13]. To test whether HDAC1 or possibly other HDACs had this
effect on the expression of slug, we used an HDACI on the ERα-
positive MDA-MB-468 clone 17 (Figure 4A). In addition we
examined the effects of HDAC inhibition on slug expression in
the ERα-positive MCF-7 line. Our results indicated that HDAC
inhibition increased slug expression in both lines. The level of
slug mRNA in MDA-MB-468 clone 17 treated with HDACI
was increased more than 4-fold compared with vehicle control
(Figure 4A).
Based on the aforementioned ﬁndings, we hypothesized that
HDACs bind to the promoter regulatory regions of slug in the
same−456to−68regionasERα bindsandformpartofthetran-
scriptional complex that regulates slug transcription. To investig-
ate this, we performed ChIP assays. In the ERα-positive MCF-7
cells, E2 treatment led to the selective recruitment of HDAC1, but
not HDAC3 or HDAC4, to the −456 to −68 region of the slug
promoter (Figure 4B). HDAC3 was present before E2 treatment,
but its recruitment was decreased after E2 treatment. There were
low levels of associated HDAC4 that did not change after E2
treatment. Our ﬁndings indicated that only HDAC1 was recruited
to the slug promoter after E2 treatment. Thus HDAC1 is the co-
repressor that forms the inhibitory complex with ligand-activated
ERα to repress slug transcription.
N-CoR, but not SRC-3 or IKKα, binds to the regulatory regions of
the slug promoter
The co-repressor N-CoR is involved in repression associated with
unliganded RAR (retinoic acid receptor) and thyroid hormone
receptor[14,15].IthadbeendemonstratedthatN-CoRalsoplayed
an important role in the regulation of ERα target genes [16,17] by
binding to ligand-activated ERα. It had also been demonstrated
thatIKKα andSRC-3regulateERα targetgenes,includingcyclin
D1 and c-Myc [18], by binding to ligand-activated ERα.F o r
these reasons we investigated whether these co-repressors or co-
activators associated with the slug promoter at the same −456
to −68 site that ERα bound and HDAC1 associated. The ERα-
positive MCF-7 line was again used in the ChIP assay. E2 treat-
ment led to the recruitment of N-CoR (Figure 5A), but not SRC-3
or IKKα (Figure 5B), to the −456 to −68 region of the slug
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Figure 3 ChIP assays for ligand-activated ERα in association with the slug promoter
(A) The ERα-positive MCF-7 cells were grown in Phenol-Red-free DMEM supplemented with 5% DCC-FBS for 48h. After 12h of serum starvation, the cells were treated with either ethanol vehicle
(control) or E2 (100nM) for 4h. ChIP assays were performed by using an antibody directed against ERα. E2 treatment led to the recruitment of ERα to the −456 to −68 but not the −2178 to
−1973 region of the slug promoter. (B) The ERα-negative MDA-MB-468 cells were similarly grown, treated and studied. There was no association of ERα to the −456 to −68 region of the slug
promoter with E2 treatment. Input DNA was used to normalize results in both sets of experiments. (C) The schematic diagram depicts the location of the three half-site EREs found at positions
−467, +182 and +241 in the slug promoter. Because these half-site EREs were only putative binding sites, we ampliﬁed a region ﬂanked by these EREs which would be immunoprecipitated if the
transcriptional inhibitory complex were bound to any one of them.
promoter. These results suggested that N-CoR, but neither SRC-3
nor IKKα, was involved in the ligand-activated ERα regulation
of slug transcription.
E2, ERα, HDAC1 and N-CoR form a co-repressor
inhibitory complex
We have proposed a model to suggest that N-CoR and HDAC1
act as co-repressors that form an inhibitory complex with E2–
ERα to suppress the expression of the slug gene. However, it is
also possible that N-CoR and HDAC1 separately associated with
the slug promoter without forming a complex with E2–ERα.I f
E2–ERα indeed formed a complex that included N-CoR and/or
HDAC1, a positive signal should be observed by Re-ChIP using
ERα and N-CoR/HDAC1 antibodies in the presence of E2. In
addition, a SeqChIP analysis with ERα and N-CoR/HDAC1
antibodies would be expected to demonstrate that after the ﬁrst
ChIP with ERα, all of the N-CoR/HDAC1 would be immuno-
precipitated and there would be nothing left to precipitate if there
was no ERα-independent recruitment of these proteins to the slug
promoter. We performed SeqChIP and Re-ChIP analyses [19,20]
to investigate these possibilities (Figures 6A and 6B). First, after
E2treatmentandsubsequentimmunoprecipitationwithanti-ERα,
we immunoprecipitated the supernatant sequentially with anti-N-
CoR, anti-HDAC1 and anti-HDAC3. Our results showed that,
after the ﬁrst ChIP with anti-ERα, subsequent immunoprecip-
itations produced no increases in the −456 to −68 slug promoter
ampliﬁcations (Figure 6B). These ﬁndings suggested that neither
N-CoR nor HDAC1 bound to the slug promoter independently of
the E2–ERα complex. Secondly, after E2 treatment, we conduc-
ted Re-ChIP on the initial anti-ERα immunoprecipitate, resus-
pended it and then immunoprecipitated it a second time sepa-
rately with anti-ERα, anti-N-CoR, anti-HDAC1 and anti-HDAC3
antibodies.Wewereabletodemonstratethatthesecondimmuno-
precipitations with anti-ERα, anti-N-CoR and anti-HDAC1 anti-
bodies, but not anti-HDAC3, produced increased slug promoter
ampliﬁcations (Figure 6A). This latter Re-ChIP indicated that
N-CoR and HDAC1 indeed formed a complex with E2–ERα.
These results suggest that ligand-activated ERα formed a
transcriptional inhibitory complex comprised of N-CoR and
HDAC1 which bound to the slug promoter (Figure 7).
DISCUSSION
As the major signalling pathways in breast cancer continue to
be identiﬁed and characterized, it is also important to identify
interactions between these pathways whenever they are present to
gain a wider understanding of signalling in the breast cancer cell.
Two of the most common signalling pathways in breast cancer
are the ERα ligand activation pathway and the E-cadherin–snai1–
slug–EMT pathway [1–4]. Although these pathways have been
shown to interact indirectly [11], the present study is the ﬁrst to
observe direct interactions between these pathways characterized
by the suppression of slug expression by ligand-activated ERα.
More speciﬁcally, ligand-activated ERα suppressed expression of
slug by direct repression of transcription. Although the prevailing
beliefisthatagonist-ligandedERα isusuallyassociatedwithgene
activation,andthattherecruitmentofgenerepressioncomponents
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Figure 4 HDAC1 presence in the inhibitory ERα transcriptional complex at
the slug promoter and its regulation of slug expression
(A) MDA-MB-468 clone 17, which overexpressed transfected ERα and showed signiﬁcant slug
inhibition with E2, was incubated in Phenol-Red-free DMEM supplemented with 5% DCC-FBS
for 48h, followed by 12h of serum starvation. Cells were then incubated for 4 h with or without
E2 (100nM) and with or without an HDACI for 2h. Total RNA was extracted and analysed
for slug mRNA by real-time PCR. HDACI enhanced slug expression. Values are means+ −S.D.
(B) MCF-7 cells were grown in Phenol-Red-free DMEM supplemented with 5% DCC-FBS for
48 h. After 12h of serum starvation, the cells were either treated with vehicle ethanol or with
100nM E2 for 4h. ChIP assays were performed using antibodies directed against HDAC1,
HDAC3 and HDAC4. E2 treatment led to the selective recruitment of HDAC1, but not HDAC3 or
HDAC4,tothe−456to−68regionoftheslugpromoter.InputDNAwasusedtonormalizethe
results.
Figure5 N-CoR,butnotIKKα orSRC-3,presencewithintheinhibitoryERα
transcriptional complex of the slug promoter
MCF-7cellsweregrowninPhenol-Red-freeDMEMsupplementedwith5%DCC-FBSfor48h,
and after 12h of serum starvation, the cells were treated either with vehicle ethanol or with
E2 (100nM) for 4h. ChIP assays were performed by using antibodies directed against N-CoR
(A), IKKα and SRC-3 (B). E2 treatment led to the recruitment of N-CoR, but not SRC-3 or
IKKα,t ot h e−456 to −68 region of the slug promoter. Input DNA was used to normalize the
results.
Figure 6 The results of SeqChIP and Re-ChIP
MCF-7cellsweregrowninPhenol-Red-freeDMEMsupplementedwith5%DCC-FBSfor48h,
and after 12 h of serum starvation, the cells were treated with either vehicle ethanol or with
100nM E2 for 4 h. The cells were collected and chromatin from 5×108 cells was incubated
ﬁrst with ERα antibody and the immune-precipitated complexes were then collected with the
additionofSepharoseA/Gplusagarosebeads.Theprecipitatedcomplexes(A)andsupernatant
(B) of each sample were used for further sequential ChIP with ERα, HDAC3, HDAC1 or N-CoR
antibodies respectively. The amount of input promoter DNA is also shown.
Figure 7 Schematic diagram summarizes direct ERα-mediated repression
of slug transcription
such as HDAC1 by ERα to target gene promoters occurs
only when ERα is liganded with antagonists [6], in the present
study we show the opposite: that ligand-activated ERα with
HDAC1 suppresses slug expression.
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Althoughtherehavebeennumerousstudiesthathaveaddressed
theERα ligandactivationpathwayandtheE-cadherin–snai1–slug
EMT pathway, very few studies have addressed their interactions.
Although it had been noted that ERα can repress the expression
of snai1 through the activation of MTA3 (metastasis-associated
1 family, member 3) that selectively targets snai1, but not slug,
direct effects on either snai1 or slug transcription were not found
[11]. In the present study we found direct effects of ERα on slug
transcription.
Our laboratory had been studying E-cadherin expression in a
series of ERα-positive and ERα-negative human breast cancer
cell lines [21] when we observed by expression proﬁling that
many ERα-negative lines which were also E-cadherin-negative
(e.g. MDA-MB-468 and MDA-MB-231) exhibited high slug
expression. Conversely, in many ERα-positive lines which were
also E-cadherin positive, we observed that slug expression was
loworabsent.Theseinitialobservationssuggestedthattheligand-
activatedERα mightregulateslugexpressionandtherebyinteract
with the E-cadherin–snai1–slug EMT signalling pathway. For
this reason we decided to investigate this interaction more fully.
In the present study, we addressed one mechanism by which
ERα controlled the expression of slug. This mechanism was that
ligand-activatedERα suppressedslugtranscriptionthroughdirect
association with the slug promoter, where ERα interacted with
recruited co-regulators. Therefore slug was an ERα-responsive
gene.
Human breast cancers which lack ligand-activated ERα may
then overexpress slug, which may down-regulate E-cadherin and
lead to EMT. EMT is thought to be a cause of biological aggress-
iveness, invasion and metastasis. Breast cancers, on the other
hand, which possess ligand-activated ERα may express low or
absent levels of slug, increased E-cadherin, decreased EMT and
less aggressive behaviour. No model is universal and there are
certainly ERα-positive breast cancers such as inﬁltrating lobular
cancer which strongly express ERα but are negative for E-
cadherin and manifest EMT. Conversely there are ERα-negative
breast cancers, such as inﬂammatory breast cancer, that are
stronglyE-cadherinpositive[22].Wehaveobservedintheselatter
cancers overexpression of snai1 and slug, and believe that the
basis of E-cadherin overexpression in inﬂammatory breast cancer
is related to altered E-cadherin trafﬁcking, increased rates of
accumulation and lack of degradation, rather than transcriptional
regulation (Y. Ye, W. Wang, K. Yearsley, J.-X. Gao and S. H.
Barsky, unpublished work).
The present studies show that E2 treatment resulted in down-
regulationofslugintransfectedMDA-MB-468clonesexpressing
full-length ERα. In addition to examining the effects of ERα
overexpression, our studies examined the effects of ERα gene
knockdown in a naturally expressing ERα line, e.g. MCF-7,
in order to monitor the effects on endogenous slug expression.
The result of ERα knockdown was a signiﬁcant increase in slug
mRNA levels even though the effect could be partially reversed
by treatment of the cells with E2, based on our hypothesis that
therewasstillsigniﬁcantresidualERα.Tosupportthishypothesis
further, near-complete knockdown was achieved with siRNA and
the effect of E2 on slug repression was completely abolished. The
overexpression and knockdown studies of ERα in tandem reveal
that the efﬁcacy of the effect of ERα on slug repression was
dependent on the overall level of ERα. These observations
conﬁrmed that slug indeed was an E2-responsive gene.
Our ﬁndings indicated that ligand-activated ERα forms, to-
getherwithHDAC1andN-CoR,atranscriptionalinhibitorycom-
plex which probably binds to the slug promoter in a region con-
taining half-site EREs. Because we did not know which of these
half ERE sites might be the location of the binding of the
transcription inhibitory complex, we chose a promoter region
ﬂanked by these sites that would probably be precipitated in the
ChIP analyses if any of these half ERE sites were involved. Our
ﬁndings still do not indicate the precise location of the binding of
the complex or whether more than one half ERE site is involved.
OurﬁndingswithSeqChIPdoconﬁrmthatE2–ERα, HDAC1 and
N-CoR together form an inhibitory complex and that HDAC1
and N-CoR do not independently associate with the slug
promoter.
It has been demonstrated previously that the recruitment of co-
regulatory proteins to ERα is required for ERα-mediated tran-
scriptional and biological activities [13,16–18] and that these
co-regulatory proteins may include HDACs, N-CoR, SRC-3 and
IKKα. In the case of slug, however, these co-regulatory proteins
speciﬁcallyincludedHDAC1andN-CoR,butnototherHDACsor
SRC-3 or IKKα. Predictably, an HDACI increased slug express-
ion. Although HDACIs are thought to have global effects on gene
expression and therefore could have increased slug expression
by other indirect or secondary mechanisms, the ﬁnding that E2
increased the HDAC1, but not other HDACs that were immuno-
precipitated from the same region of the slug promoter (−456
to −68) where ligand-activated ERα was immunoprecipitated,
indicated that ERα was probably the target for HDACI-alleviated
slug gene expression. This ﬁnding further conﬁrmed that ligand-
activated ERα suppressed slug expression by transcriptional
repressionandthattheERligandactivationpathwayinteractswith
the E-cadherin–snai1–slug EMT pathways directly by repressing
slug.
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